Hexavac (diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted)
- Region
- 🇪🇺 EU
- Active substance
- diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted
- Company
- Sanofi Pasteur MSD, SNC
- Status
- Withdrawn
- Therapeutic area
- Hepatitis B; Tetanus; Immunization; Meningitis, Haemophilus; Whooping Cough; Poliomyelitis; Diphtheria
- EU approval
- Mon 23 Oct 2000
- Application
- EMEA/H/C/000298
- ATC
- J07CA
- Official record
- www.ema.europa.eu
Indication
This combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis B caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by Haemophilus influenzae type b.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Infanrix Hexa Authorised · GlaxoSmithKline Biologicals S.A.
- 🇪🇺 Hexacima Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Hexyon Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Vaxelis Authorised · MCM Vaccine B.V.
- 🇪🇺 Tritanrix HepB Lapsed · GlaxoSmithKline Biologicals S.A.
- 🇪🇺 Infanrix Penta Lapsed · GlaxoSmithKline Biologicals S.A.
- 🇪🇺 Quintanrix Withdrawn · GlaxoSmithKline Biologicals S.A.
- 🇪🇺 Infanrix HepB Withdrawn · GlaxoSmithKline Biologicals S.A.
- 🇪🇺 Triacelluvax Withdrawn · Chiron S.p.A.
- 🇪🇺 Primavax Withdrawn · Pasteur Mà¨rieux MSD
Follow Hexavac
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.